FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

385178005: Conventional release vaginal tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479441013 Vaginal tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3537394010 Conventional release vaginal tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3537395011 Conventional release vaginal tablet (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release vaginal tablet Is a Vaginal dose form true Inferred relationship Existential restriction modifier
Conventional release vaginal tablet Is a Tablet false Inferred relationship Existential restriction modifier
Conventional release vaginal tablet Has dose form administration method Insert true Inferred relationship Existential restriction modifier
Conventional release vaginal tablet Has dose form intended site Vaginal true Inferred relationship Existential restriction modifier
Conventional release vaginal tablet Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release vaginal tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier
Conventional release vaginal tablet Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Conventional release effervescent vaginal tablet Is a True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form False Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely clotrimazole 500 milligram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely nystatin 100000 unit/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely progesterone 100 milligram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely misoprostol 25 microgram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely misoprostol 100 microgram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely misoprostol 200 microgram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely estradiol 10 microgram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form False Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form False Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has manufactured dose form False Conventional release vaginal tablet Inferred relationship Existential restriction modifier
Prostin E2 3mg vaginal tablets (Pfizer Ltd) Has manufactured dose form True Conventional release vaginal tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start